Your browser doesn't support javascript.
loading
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
Faleck, David M; Winters, Adam; Chablaney, Shreya; Shashi, Preeti; Meserve, Joseph; Weiss, Aaron; Aniwan, Satimai; Koliani-Pace, Jenna L; Kochhar, Gursimran; Boland, Brigid S; Singh, Siddharth; Hirten, Robert; Shmidt, Eugenia; Kesar, Varun; Lasch, Karen; Luo, Michelle; Bohm, Matthew; Varma, Sashidhar; Fischer, Monika; Hudesman, David; Chang, Shannon; Lukin, Dana; Sultan, Keith; Swaminath, Arun; Gupta, Nitin; Siegel, Corey A; Shen, Bo; Sandborn, William J; Kane, Sunanda; Loftus, Edward V; Sands, Bruce E; Colombel, Jean-Frederic; Dulai, Parambir S; Ungaro, Ryan.
Afiliação
  • Faleck DM; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Winters A; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Chablaney S; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Shashi P; Cleveland Clinic Foundation, Cleveland, Ohio.
  • Meserve J; University of California - San Diego, La Jolla, California.
  • Weiss A; Montefiore Medical Center, Bronx, New York.
  • Aniwan S; Mayo Clinic, Rochester, Minnesota.
  • Koliani-Pace JL; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Kochhar G; Cleveland Clinic Foundation, Cleveland, Ohio.
  • Boland BS; University of California - San Diego, La Jolla, California.
  • Singh S; University of California - San Diego, La Jolla, California.
  • Hirten R; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Shmidt E; University of Minnesota, Minneapolis, Minnesota.
  • Kesar V; Lenox Hill Hospital, New York, New York.
  • Lasch K; Takeda Pharmaceuticals U.S.A., Inc, Deerfield, Illinois.
  • Luo M; Takeda Pharmaceuticals U.S.A., Inc, Deerfield, Illinois.
  • Bohm M; Indiana University, Indianapolis, Indiana.
  • Varma S; Indiana University, Indianapolis, Indiana.
  • Fischer M; Indiana University, Indianapolis, Indiana.
  • Hudesman D; New York University, New York, New York.
  • Chang S; New York University, New York, New York.
  • Lukin D; Montefiore Medical Center, Bronx, New York.
  • Sultan K; North Shore University Hospital, Manhasset, New York.
  • Swaminath A; Lenox Hill Hospital, New York, New York.
  • Gupta N; University of Mississippi, Jackson, Mississippi.
  • Siegel CA; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Shen B; Cleveland Clinic Foundation, Cleveland, Ohio.
  • Sandborn WJ; University of California - San Diego, La Jolla, California.
  • Kane S; Mayo Clinic, Rochester, Minnesota.
  • Loftus EV; Mayo Clinic, Rochester, Minnesota.
  • Sands BE; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Colombel JF; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Dulai PS; University of California - San Diego, La Jolla, California. Electronic address: pdulai@ucsd.edu.
  • Ungaro R; Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: ryan.ungaro@mssm.edu.
Clin Gastroenterol Hepatol ; 17(12): 2497-2505.e1, 2019 11.
Article em En | MEDLINE | ID: mdl-30625408

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Indução de Remissão / Fármacos Gastrointestinais / Colite Ulcerativa / Doença de Crohn / Anticorpos Monoclonais Humanizados Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Gastroenterol Hepatol Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Indução de Remissão / Fármacos Gastrointestinais / Colite Ulcerativa / Doença de Crohn / Anticorpos Monoclonais Humanizados Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Gastroenterol Hepatol Ano de publicação: 2019 Tipo de documento: Article